PER 0.00% 10.0¢ percheron therapeutics limited

technicals, page-20

  1. 56 Posts.
    Thanks Itsagas

    Most of the attention has been on the therapeutic benifit of ATL1103 which in itself should be life changing for both paitent and investor but i still believe ATL1102 will be the bread and butter of ANP,

    I say again $5 in 5 years is noy unreasonable, "maybe 3 years"

    JB
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.